PolyNovo (ASX: PNV) — Company Overview, News & Financial Data
PolyNovo develops regenerative medical products for treating burns and chronic wounds, focusing on innovative solutions.
PolyNovo
PolyNovo is a medical device company focused on the development and commercialization of bioresorbable synthetic polymer technologies for reconstructive wound care and surgical applications. The company manufactures synthetic dermal scaffold products designed to assist in the treatment of full and partial-thickness burns, surgical wounds, trauma injuries, and chronic ulcers. Its proprietary polymer material fully degrades via hydrolysis, providing a temporary matrix that supports dermal tissue regeneration before absorbed by the body. Operating global manufacturing facilities in Australia, the company distributes its surgical devices across North America, Europe, Asia-Pacific, and other international healthcare markets.
Snapshot
Operations
Products and/or services of PolyNovo
- Dermal Reconstruction Matrices: Engineered bioresorbable synthetic matrices facilitate dermal tissue regeneration in full-thickness burns, surgical wounds, and complex trauma cases, supporting tissue ingrowth prior to skin grafting across major hospital systems in North America, Europe, and Asia-Pacific.
- Major Trauma and Burn Care: Specialized synthetic wound care scaffolds designed for critical care burn units and emergency surgical trauma centers, aiding soft tissue replacement and reducing contracture risk during extensive reconstructive procedures in inpatient settings globally.
- Outpatient Wound Management: Synthetic tissue matrices tailored for outpatient wound care facilities, addressing non-healing diabetic foot ulcers, venous leg ulcers, and chronic pressure sores through specialized outpatient clinical protocols and specialized wound care centers.
- Hernia and Fascial Repair Systems: Development of bioresorbable synthetic meshes engineered for abdominal wall reconstruction, complex hernia repair, and soft tissue reinforcement to mitigate surgical complications and reduce long-term foreign body responses in patients.
- Breast Reconstruction Solutions: Development of specialized bioresorbable matrix implants designed for soft tissue support following post-mastectomy surgical reconstruction, offering a synthetic alternative to human or animal tissue-derived matrices in plastic and reconstructive surgery.
- Drug Delivery and Biomaterial Platforms: Applied research into antimicrobial-impregnated synthetic polymers and bioresorbable drug-eluting matrices designed to release therapeutic agents controlledly while supporting cell growth and tissue regeneration during specialized medical procedures.
PolyNovo executive team
- Mr. Jan-Marcel Gielen C.A.CFO & Company Secretary
- Mr. Bruce PeateyChief Executive Officer
- Ms. Kimberley AxonChief People Officer
- Mr. Edward GraubartPresident of North America
- Mr. Ahmed HassanChief Manufacturing & Supply Chain Officer